Implantable cardioverter defibrillators: Uses, abuses, gains and complications
Sudden cardiac death (SCD) due to a ventricular arrhythmia is one of the most common causes of death, yet its management continues to be a challenge. Controlled clinical trials have provided evidence that implantable cardioverter defibrillators (ICDs) are effective in reducing the risk of SCD in sel...
Guardado en:
Autores principales: | Weiwei Li, Brian Olshansky |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
South African Heart Association
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8498874455444f71ac23c801a0f43ca4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Wearable Cardioverter-Defibrillator Used as a Telemonitoring System in a Real-Life Heart Failure Unit Setting
por: Christian Blockhaus, et al.
Publicado: (2021) -
Risk Factors and Temporal Trends of Complications Associated With Transvenous Implantable Cardiac Defibrillator Leads
por: Jayanthi N. Koneru, et al.
Publicado: (2018) -
Right Ventricular Endocardial Mapping and a Potential Arrhythmogenic Substrate in Cardiac Amyloidosis—Role of ICD
por: Aleksandra Liżewska-Springer, et al.
Publicado: (2021) -
Absence of Obesity Paradox in All-Cause Mortality Among Chinese Patients With an Implantable Cardioverter Defibrillator: A Multicenter Cohort Study
por: Bin Zhou, et al.
Publicado: (2021) -
Lead dislodgement after a very long‐term period of cardiac implantable electronic device implantation
por: Hidehiro Iwakawa, et al.
Publicado: (2021)